Brean Murray Carret & Co. Starts Achillion Pharmaceuticals (ACHN) at Buy, $9 Pirce Target
Tweet Send to a Friend
Brean Murray Carret & Co. initiates coverage on shares of Achillion Pharmaceuticals (NASDAQ: ACHN) with a Buy rating and $9 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
